Federal award (PURCHASE ORDER, fiscal year 2023)
Recipient: RLS (USA) INC.
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2023-10-23 to 2024-09-30
Current total value of award: $249158.11
Description: RADIOPHARMACEUTICALS